Abstract
Cancer incidence was investigated in a cohort of 700 workers employed at a Connecticut chemical plant between mid-1965 and 1989. The plant produced a variety of chemicals, including arylamines such as dichlorobenzidine (DCB), o-dianisidine, o-tolidine, but not benzidine. Benzidine production ceased prior to mid-1965. The principal finding was a statistically significant increase in the standardized incidence ratio (SIR) for bladder cancer in men (SIR = 8.3; confidence interval, 3.3 to 17.0). Based on an exposure classification system developed by a panel of former and current employees, the observed association between bladder cancer cases and exposure to arylamines increased with increasing exposure (SIRs = 0.0, 5.5, 16.4, for none, low, or moderate levels of exposure, respectively). Smoking probably contributed to the bladder cancer risk, as all case subjects were known to be current or former cigarette smokers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of occupational and environmental medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
